Terns Pharmaceuticals, Inc. Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERN

Ранг среди акций #3573
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Цена акции
$52.95
Последняя синхронизация: 2026-05-15
Рыночная капитализация
$4.77B
Изменение (1 день)
0.00%
Изменение (1 год)
514.27%
Страна
US
Торговля Terns Pharmaceuticals, Inc. (TERN)

Категория

Healthcare
История дроблений акций Terns Pharmaceuticals, Inc. (TERN)
Акции Terns Pharmaceuticals, Inc. (символ: TERN) прошли через 0 дроблений.
Последнее дробление произошло Oct 20, 2026.
Одна акция TERN, купленная до Oct 20, 2026, сейчас соответствует 0 акциям TERN.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL